BioNTech is executing a fundamental strategic realignment, moving decisively away from its pandemic-related business toward an intensified focus on cancer medicine. The company is bolstering its ...

PDS Biotech has reported final phase 2 data on PDS0101 in the tough-to-treat head and neck cancer setting, linking a combination of the immunotherapy and Keytruda to median overall survival (OS) of 39 ...

On August 23, 2021 the Food and Drug Administration fully approved the Phizer-BioNTech COVID-19 Vaccine for adults.

Learn about the major world events and happenings, birthdays, and deaths that took place on August 23. Check what happened ...

The retreat signals that the federal government is capricious and weak and easily persuaded by misinformation.

For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine ...